Enzo Biochem, Inc.
Hedge Funds Holdings
Last updated:
Enzo Biochem, Inc.‘s stocks are currently a part of 30 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 12.27M shares of Enzo Biochem, Inc.. Compared to the previous quarter, the number fell by -34.62% or -6.49M shares fewer. As for the holding position changes, 10% (3) of current hedge fund investors increased the number of shares held, 30% (9) of current holders sold a part of the shares held, and 26.67% (8) closed the holdings completely. 7 hedge funds are new holders of Enzo Biochem, Inc. stock in Q1 2023, it is 23.33% of total holders.
Hedge funds holding Enzo Biochem (Q2 2018 – Q1 2023)
| Q2 2018 | 95 |
|---|---|
| Q3 2018 | 93 |
| Q4 2018 | 83 |
| Q1 2019 | 78 |
| Q2 2019 | 90 |
| Q3 2019 | 82 |
| Q4 2019 | 75 |
| Q1 2020 | 71 |
| Q2 2020 | 79 |
| Q3 2020 | 77 |
| Q4 2020 | 79 |
| Q1 2021 | 77 |
| Q2 2021 | 66 |
| Q3 2021 | 59 |
| Q4 2021 | 55 |
| Q1 2022 | 47 |
| Q2 2022 | 49 |
| Q3 2022 | 44 |
| Q4 2022 | 49 |
| Q1 2023 | 30 |
Hedge funds changes in Enzo Biochem positions (Q2 2018 – Q1 2023)
| Q2 2018 | 12 | 27 | 39 | 21 | -4 |
|---|---|---|---|---|---|
| Q3 2018 | 12 | 32 | 30 | 14 | 5 |
| Q4 2018 | 7 | 20 | 34 | 18 | 4 |
| Q1 2019 | 9 | 27 | 24 | 14 | 4 |
| Q2 2019 | 19 | 27 | 26 | 4 | 14 |
| Q3 2019 | 5 | 25 | 32 | 13 | 7 |
| Q4 2019 | 4 | 25 | 23 | 11 | 12 |
| Q1 2020 | 8 | 21 | 27 | 10 | 5 |
| Q2 2020 | 14 | 28 | 21 | 6 | 10 |
| Q3 2020 | 9 | 22 | 27 | 11 | 8 |
| Q4 2020 | 8 | 24 | 24 | 6 | 17 |
| Q1 2021 | 9 | 18 | 33 | 11 | 6 |
| Q2 2021 | 16 | 9 | 31 | 27 | -17 |
| Q3 2021 | 6 | 11 | 22 | 13 | 7 |
| Q4 2021 | 10 | 9 | 17 | 14 | 5 |
| Q1 2022 | 3 | 13 | 14 | 11 | 6 |
| Q2 2022 | 6 | 8 | 14 | 4 | 17 |
| Q3 2022 | 2 | 6 | 11 | 7 | 18 |
| Q4 2022 | 9 | 10 | 13 | 3 | 14 |
| Q1 2023 | 7 | 3 | 9 | 8 | 3 |
Hedge funds changes in Enzo Biochem stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 376,000 | 37,000 |
|---|---|---|
| Q3 2018 | 352,000 | 6,000 |
| Q4 2018 | 2,000 | 1,000 |
| Q1 2019 | 18,000 | 1,000 |
| Q2 2019 | 174,000 | 0 |
| Q3 2019 | 37,000 | 0 |
| Q4 2019 | 19,000 | 1,000 |
| Q1 2020 | 277,000 | 72,000 |
| Q2 2020 | 113,000 | 234,000 |
| Q3 2020 | 149,000 | 169,000 |
| Q4 2020 | 364,000 | 2,861,000 |
| Q1 2021 | 492,000 | 6,228,000 |
| Q2 2021 | 343,000 | 3,846,000 |
| Q3 2021 | 496,000 | 3,034,000 |
| Q4 2021 | 205,000 | 430,000 |
| Q1 2022 | 253,000 | 155,000 |
| Q2 2022 | 115,000 | 109,000 |
| Q3 2022 | 179,000 | 740,000 |
| Q4 2022 | 36,608 | 587,851 |
| Q1 2023 | 217,756,000 | 30,887,000 |